Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

75.07
BATS BZX Real-Time Price
As of 1:10pm ET
 +1.14 / +1.54%
Today’s Change
31.38
Today|||52-Week Range
80.11
+100.51%
Year-to-Date

Today’s Trading

Previous close73.93
Today’s open74.30
Day’s range74.30 - 75.73
Volume24,890
Average volume (3 months)989,518
Market cap$6.2B
Dividend yield--
Data as of 1:10pm ET, 05/23/2017

Growth & Valuation

Earnings growth (last year)-38.84%
Earnings growth (this year)-11.01%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+14.75%
P/E ratioNM
Price/Sales67.96
Price/Book6.69

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA-0.11-0.51%
UTHRUnited Therapeutics ...-1.53-1.25%
RDYDr.Reddy's Laborator...-1.56-3.85%
IONSIonis Pharmaceutical...+0.13+0.29%
Data as of 1:11pm ET, 05/23/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$1.24
Annual revenue (last year)$47.2M
Annual profit (last year)-$410.1M
Net profit margin-869.63%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts